The immunogenicity team presented a poster at Antibody Engineering and Therapeutics Europe in June 2024. This poster—Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics—discusses our approach to minimizing immunogenicity risks.
Complete the form to view/download this poster.
Related Insights
Specifica Antibody Discovery Campaigns
Specifica Library Platform Transfer
Specifica Affinity Maturation & Developability Optimization
Discovery Sciences – Innovative Antibody Drug Discovery Services
Immunogenicity Assessment and Functional Testing of Candidate Therapeutics
Presented by Chloe Ackaert, PhD at AAPS PharmSci360 in 2023
Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis
Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs
In vitro functional evaluation of immuno-oncology drug candidates in customized bioassays
Monoclonal Antibodies Reagents
